We are the International AIDS Society

We convene, educate and advocate for a world in which HIV no longer presents a threat to public health and individual well-being.

Learn more
Girl holding a red AIDS ribbon

Registration and activity submissions for AIDS 2024, the 25th International AIDS Conference, are now open!

The IAS unites the global HIV response because progress happens when science, policy and activism come together. Here’s how we do this:

Munich, Germany

AIDS 2024

The 25th International AIDS Conference

AIDS 2024, the 25th International AIDS Conference, will take place in Munich, Germany, and virtually from 22 to 26 July 2024 and is expected to bring together some 18,000 participants from around the world.

View details

Events

14 Mar 2024
Why putting people first in the HIV response makes sense

IAS – the International AIDS Society – in partnership with LoveYourself are co-organizing a workshop, titled “Why putting people first in the HIV response makes sense”, in Manila on 14-15 March 2024. This workshop is a regional meeting following IAS 2023, the 12th IAS Conference on HIV Science, to provide access to and discuss the latest evidence-based science in the local context.

Speakers and participants will discuss:

View details View details
2 May 2024
HIV science and community: Progress and challenges in Pakistan

IAS – the International AIDS Society – in partnership with Nai Zindagi and Aga Khan University, is organizing a scientific symposium, titled “HIV science and community: Progress and challenges in Pakistan”, in Islamabad on 2-3 May 2024. This symposium is a regional meeting following IAS 2023, the 12th IAS Conference on HIV Science, to provide access to and discuss the latest evidence-based science in the local context.

Speakers and participants will discuss:

View details View details
7 May 2024
2024 HIV Vaccine Science Academy

The HIV Vaccine Science Academy aims at supporting early- and mid-career investigators conducting HIV vaccine research in Africa by providing opportunities for training, networking and mentorship. The Academy is designed to support the participants in establishing themselves as independent researchers and team leaders in their respective host institutions, thus contributing to long-term continuity, networking and research ownership in central, eastern, southern and western Africa in the effort to develop a safe and effective HIV vaccine.

The HIV Vaccine Science Academy offers: 

View details View details
See us make a difference

Sign up to receive our newsletter. Stay updated on our efforts and impact and learn how to make a difference.

The IAS at a glance

We unite scientists, policy makers and activists to galvanize the scientific response, build global solidarity and enhance human dignity for all people living with and affected by HIV. Here are some numbers that show how we do that.

676

IAS change makers. Carefully selected HIV researchers, advocates, healthcare providers and others we educate to drive an evidence-based HIV response that puts people first.

13,000+

IAS Members worldwide. We convene people from diverse backgrounds to drive a shared vision of a world in which HIV is no longer a threat to public health and individual well-being.

4,137

Scientific studies shared via our conferences and JIAS in 2020/21. We advocate for evidence-based progress to improve the lives of people living with and affected by HIV.